Frontier Medicine Corporation

Frontier Medicine Corporation was founded in 2018 and headquartered in San Francisco, California, USA. Frontier Medicine is a Biopharmaceutical Company To develop a chemical proteomics platform to accelerate drug development.

The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

Frontier Medicine Corporation

Frontier Medicine is a precision medical company, which has created a proprietary discovery and development platform for the development of drugs for pathogenic proteins that were previously thought to be unable to be made into drugs. Frontier Medicine is deploying breakthrough scientific methods in chemical proteomics, covalent drug discovery and machine learning to develop drugs, starting with anti-cancer therapy. Frontier Medicine gave priority to a series of high impact goals when developing the company's wholly-owned pipeline. These projects reflect its vision of developing precise drugs for important oncology goals, which can bring meaningful benefits to patients. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

One of the innovations of Frontier Medicine is that it uses chemical proteomics technology, which is a novel method combining chemistry and biology to reveal the relationship between protein structure and function. Through this technology, Frontier Medicines can develop highly selective and effective small molecule drugs for targets, so as to provide better treatment options for patients. Frontier Medicine's research focuses on targeting cancer driving genes, signal pathways and proteins, as well as other key molecules related to disease occurrence and development. The mission of the company is to use the latest science and technology to provide patients with innovative treatment methods and make major breakthroughs in the medical field. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

The leading project of Frontier Medicine is FMC-376, which is a new dual inhibitor of KRASG12C, both active and inactive. KRASG12C mutation is most common in patients with non-small cell lung cancer, colorectal cancer and pancreatic cancer. In addition, Frontier Medicine and abbvie (AbbVie) has established a global partnership to discover and develop new therapies targeting a certain number of oncology and immunology targets, as well as targeted protein degradation technology based on the new E3 ligase. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

Frontier Medicine Corporation Financing Encyclopedia

In June 2019, Frontier Medicine Corporation completed the round A financing of 67 million US dollars led by Deerfield, Droia Ventures and MPM Capital, RA Capital Management 、 DCVC Co investment of Bio and Berkeley Catalyst Fund (BCF). The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

In July 2019, Frontier Medicine Corporation completed RA Capital Management And Woodline Partners, and ArrowMark Partners, Deep Track Capital and Driehaus Capital Management. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

In July 2021, Frontier Medicines Corporation completed the US $88.5 million round B+financing led by Woodline Partners, and MPM Capital, Deepfield, ArrowMark Partners, Deep Track Capital, etc. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

In February 2024, Frontier Medicines Corporation completed the US $80 million round C financing led by Deerfield Management and Droia Ventures RA Capital Management 、 DCVC Bio, etc. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html

Frontier Medicine Corporation US equity investment

Unlisted company ， Company official website , waiting for Frontier Medicine Corporation IPO Listing. The article originates from the home of American stocks | encyclopedia of American stocks | account opening and investment of American and Hong Kong stocks- https://www.mg21.com/frontier.html